Evidence map›Paper›PMID 37427304›Full record

ReviewArrhythmia & electrophysiology review2023

Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation.

David M Harmon, Ojasav Sehrawat, Maren Maanja, John Wight, Peter A Noseworthy

Open access · goldAbstract readReview
In one paragraph

Review in Arrhythmia & electrophysiology review, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Systematic, randomized atrial fibrillation screening using detailed phenotyping with a risk prediction model combined with patch electrocardiogram in a Swedish population aged 65 years or older: the CONSIDERING-AF trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Trial
  3. Review
  4. Understanding the Diseased Atria.Physiology (Bethesda, Md.) · 2026
    Review
  5. Observational
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Device-detected Atrial Fibrillation: How Much is Too Much?Arrhythmia & electrophysiology review · 2026
    Review
  16. Review
  17. Spatial Autocorrelation Dimension (Arrhythmia & electrophysiology review · 2026
    Review
  18. Atrial fibrillation in continuous flow-left ventricular assist device (CF-LVAD) patients: impact on pathophysiology.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

David M HarmonDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, US.
Ojasav SehrawatDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, US.
Maren MaanjaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, US.
John WightDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, US.
Peter A NoseworthyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, US.
Mayo Clinic in Arizona · USMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AF is the most common clinically relevant cardiac arrhythmia associated with multiple comorbidities, cardiovascular complications (e.g. stroke) and increased mortality. As artificial intelligence (AI) continues to transform the practice of medicine, this review article highlights specific applications of AI for the screening, diagnosis and treatment of AF. Routinely used digital devices and diagnostic technology have been significantly enhanced by these AI algorithms, increasing the potential for large-scale population-based screening and improved diagnostic assessments. These technologies have similarly impacted the treatment pathway of AF, identifying patients who may benefit from specific therapeutic interventions. While the application of AI to the diagnostic and therapeutic pathway of AF has been tremendously successful, the pitfalls and limitations of these algorithms must be thoroughly considered. Overall, the multifaceted applications of AI for AF are a hallmark of this emerging era of medicine.

Indexed as

arrhythmiaAtrial fibrillationdigital healthelectrocardiogrammachine learning

Identifiers

PMID37427304
PMCPMC10326669
OpenAlexW4366389431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.